Nano-X Imaging (NNOX) Revenue & Revenue Breakdown
Nano-X Imaging Revenue Highlights
Latest Revenue (Y)
$9.90M
Latest Revenue (Q)
$2.55M
Nano-X Imaging Revenue by Period
Nano-X Imaging Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $9.90M | 15.47% |
| 2022-12-31 | $8.58M | 557.82% |
| 2021-12-31 | $1.30M | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | - |
Nano-X Imaging generated $9.90M in revenue during NA 2023, up 15.47% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Nano-X Imaging Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $2.55M | 6.51% |
| 2023-12-31 | $2.40M | -3.31% |
| 2023-09-30 | $2.48M | -3.99% |
| 2023-06-30 | $2.58M | 5.52% |
| 2023-03-31 | $2.45M | 14.77% |
| 2022-12-31 | $2.13M | -12.55% |
| 2022-09-30 | $2.44M | 10.82% |
| 2022-06-30 | $2.20M | 21.68% |
| 2022-03-31 | $1.81M | 38.65% |
| 2021-12-31 | $1.30M | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | - |
Nano-X Imaging generated $2.55M in revenue during Q1 2024, up 6.51% compared to the previous quarter, and up 119.75% compared to the same period a year ago.
Nano-X Imaging Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ABT | Abbott Laboratories | $40.11B | $10.38B |
| MDT | Medtronic | $32.36B | $7.92B |
| SYK | Stryker | $20.50B | $5.42B |
| EW | Edwards Lifesciences | $6.00B | $1.39B |
| ALGN | Align | $3.86B | $1.03B |
| DXCM | DexCom | $3.62B | $1.00B |
| IART | Integra LifeSciences | $1.54B | $418.18M |
| SWAV | ShockWave Medical | $730.23M | $218.81M |
| NVCR | NovoCure | $509.34M | $150.36M |
| AXNX | Axonics | $366.38M | $114.56M |
| PACB | Pacific Biosciences of California | $200.52M | $38.81M |
| MASS | 908 Devices | $50.23M | $14.05M |
| HYPR | Hyperfine | $11.03M | $3.63M |
| NNOX | Nano-X Imaging | $9.90M | $2.55M |
| MGRM | Monogram Orthopaedics | $365.00K | - |
NNOX Revenue FAQ
What is Nano-X Imaging’s yearly revenue?
Nano-X Imaging's yearly revenue for 2023 was $9.9M, representing an increase of 15.47% compared to 2022. The company's yearly revenue for 2022 was $8.58M, representing an increase of 557.82% compared to 2021. NNOX's yearly revenue for 2021 was $1.3M, representing an increase of 100.00% compared to 2020.
What is Nano-X Imaging’s quarterly revenue?
Nano-X Imaging's quarterly revenue for Q1 2024 was $2.55M, a 6.51% increase from the previous quarter (Q4 2023), and a 4.33% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $2.4M, a -3.31% decrease from the previous quarter (Q3 2023), and a 12.43% increase year-over-year (Q4 2022). NNOX's quarterly revenue for Q3 2023 was $2.48M, a -3.99% decrease from the previous quarter (Q2 2023), and a 1.68% increase year-over-year (Q3 2022).
What is Nano-X Imaging’s revenue growth rate?
Nano-X Imaging's revenue growth rate for the last 3 years (2021-2023) was 659.59%, and for the last 5 years (2019-2023) was 0%.